Prestige Biopharma reports Ph III results for Tuznue

Clinical Research |  News | 0 Comment | 24 Jun, 2019

Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluating the efficacy, safety, and pharmacokinetics (PK) of biosimilar cand...Read more

Parexel launches an enhanced integrated outsourcing delivery model for FSP

Clinical Research |  News | 0 Comment | 24 Jun, 2019

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through to Commercialization...Read more

Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial

Clinical Research |  News | 0 Comment | 24 Jun, 2019

Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumours and related diseases, on 24 June 20...Read more

FasT CAR-19 Therapy Shows Positive Impact in Patients with (r/r) B-ALL

Clinical Research |  News | 0 Comment | 21 Jun, 2019

Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announced preliminary results of a multi-centre pilot study d...Read more

Edesa Biotech receives approval to proceed with its clinical investigation

Clinical Research |  News | 0 Comment | 20 Jun, 2019

Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration has notified the company that it may proceed with its clinical investi...Read more

BI, Lilly announces results of new post-hoc analysis of data from the EMPA-REG OUTCOME trial

Clinical Research |  News | 0 Comment | 17 Jun, 2019

Boehringer Ingelheim and Eli Lilly and Company have announced results of a new post-hoc analysis of data from the EMPA-REG OUTCOME trial. These results indicated that the effect of empaglif...Read more

Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302

Clinical Research |  News | 0 Comment | 17 Jun, 2019

Reistone Biopharma Company Limited (Reistone), on 14 June 2019, announced dosing of the first patient in their Phase II global clinical trials (RSJ10101 and RSJ10201) of SHR0302 in patients...Read more

Lumosa to Initiate Phase 2 Human Clinical Trial for LT3001 to treat Acute Ischemic Stroke

Clinical Research |  News | 0 Comment | 14 Jun, 2019

Lumosa Therapeutics, on 13 June 2019, announced that the company is ready to commence the Phase 2 proof of concept (PoC) study for its LT3001, a novel drug for the treatment of acute ischem...Read more

China NMPA Approves Sinovant's Clinical Trial Application for Lefamulin

Clinical Research |  News | 0 Comment | 14 Jun, 2019

Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted by the Center for Drug Evaluation at the China National Medical Produc...Read more

Terns Pharmaceuticals and Shanghai Tuosheng Biotechnology initiate TERN-101 first phase trial

Clinical Research |  News | 0 Comment | 14 Jun, 2019

Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch of a clinical FXR agonist of TERN-101 Phase I trials to further supp...Read more

Dr. Reddy's announces positive results for psoriasis drug study

Clinical Research |  News | 0 Comment | 11 Jun, 2019

Dr. Reddy’s has announced positive topline results from its Phase 2b study of PPC-06 (formerly referred to as XP23829) in patients with moderate to severe plaque psoriasis. In th...Read more

Ascentage Pharma presents new clinical data of apoptosis targeted drug candidates

Clinical Research |  News | 0 Comment | 07 Jun, 2019

Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases has announced that t...Read more

CStone to initiate clinical development of CS1001 and BLU-554 in combination therapy for HCC

Clinical Research |  News | 0 Comment | 06 Jun, 2019

CStone Pharmaceuticals  has announced that it has received approval to initiate clinical development in China of CS1001 in combination with BLU-554 (CS3008) in patients ...Read more

Genentech announces meeting of primary endpoint of Ph III study

Clinical Research |  News | 0 Comment | 04 Jun, 2019

Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi & Co. Ltd. met its primary endpoint showing that people exposed to a...Read more

Saluda Medical announces clinical study results of the chronic pain treatment

Clinical Research |  News | 0 Comment | 03 Jun, 2019

Saluda Medical Pty Limited ("Saluda Medical") has announced data from two clinical studies evaluating the performance of the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Co...Read more

Innovent announces preliminary results of Sintilimab at ASCO

Clinical Research |  News | 0 Comment | 31 May, 2019

Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has announced that the preliminary results of sintilimab, the anti-P...Read more

Pi Therapeutics announces $19.7 M Series B Financing

Clinical Research |  News | 0 Comment | 30 May, 2019

Pi Therapeutics, a company dedicated to the development of novel modulators of protein degradation for cancer has announced the completion of a $19.7 million Series B financing. T...Read more

Up to six new HBV drugs set to launch by 2027, with China driving market growth, says GlobalData

Clinical Research |  News | 0 Comment | 29 May, 2019

Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B virus (HBV) infections in the eight major markets (8MM*), according...Read more